ConductScience.org, home

Paper3936263

Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases.

Søndergaard K and 1 other. Virchows Arch A Pathol Anat Histopathol, 1985. Cited by 76 papers, by iCite.

Cite this record

ConductScience Library. Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases. Papers, record 3936263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3936263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases.
PubMed
Journal
Virchows Arch A Pathol Anat Histopathol
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
3.2
iCite
Revised in PubMed
2023-02-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Søndergaard KK
2Hou-Jensen KK

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Neoplasm Regression, SpontaneousMajor topic
Skin NeoplasmsMajor topic
Adult
Female
Humans
Male
Neoplasm Staging
Prognosis

Source PubMed

Download CSV of topics

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1719608The regressing thin malignant melanoma: a distinctive lesion with metastatic potential.Cancer1978https://conductscience.org/library/papers/719608PubMed
26848075Biologic behavior of thin malignant melanomas with regressive changes.Arch Surg1983https://conductscience.org/library/papers/6848075PubMed
35477666Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.Ann Surg1970https://conductscience.org/library/papers/5477666PubMed
46821832Metastases of thin melanomas.Cancer1983https://conductscience.org/library/papers/6821832PubMed
5831755Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.Br J Cancer1977https://conductscience.org/library/papers/831755PubMed
66498388Experience of thin cutaneous melanomas (less than 0.76 mm and less than 0.85 mm thick) in a large plastic surgery unit: a 5 to 17 year follow-up.Br J Plast Surg1984https://conductscience.org/library/papers/6498388PubMed
76629343Prognosis in patients with thin malignant melanoma: influence of regression.Histopathology1983https://conductscience.org/library/papers/6629343PubMed
83923697Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis.Virchows Arch A Pathol Anat Histopathol1985https://conductscience.org/library/papers/3923697PubMed
91190862Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma.Ann Surg1975https://conductscience.org/library/papers/1190862PubMed
101153228Spontaneous regression of melanoma.Pathology1975https://conductscience.org/library/papers/1153228PubMed
116870532Biologic behavior of thin malignant melanomas with regressive changes.Arch Surg1983https://conductscience.org/library/papers/6870532PubMed

Download CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
35223178Significance of Primary Melanoma Regression on Local Infiltrate and Outcome.Dermatol Pract Concept2022https://conductscience.org/library/papers/35223178PubMed
28240749Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.Lab Invest2017https://conductscience.org/library/papers/28240749PubMed
22610274Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma.Melanoma Res2012https://conductscience.org/library/papers/22610274PubMed
21263244High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma.Am J Surg Pathol2011https://conductscience.org/library/papers/21263244PubMed
17874109[Regression in malignant melanoma. Definition, etiopathogenesis, morphology and differential diagnosis].Pathologe2007https://conductscience.org/library/papers/17874109PubMed
12669250Bcl-2 expression in metastatic malignant melanoma. Importance for the therapeutic efficacy of biochemotherapy.Cancer Immunol Immunother2003https://conductscience.org/library/papers/12669250PubMed
11747328Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes.Br J Cancer2001https://conductscience.org/library/papers/11747328PubMed
8845294Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.Br J Cancer1996https://conductscience.org/library/papers/8845294PubMed
7903405Morphometric, DNA and PCNA in thin malignant melanomas.Med Oncol Tumor Pharmacother1993https://conductscience.org/library/papers/7903405PubMed
7686347Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.Am J Pathol1993https://conductscience.org/library/papers/7686347PubMed
3401060Lethal "thin" malignant melanoma. Identifying patients at risk.Ann Surg1988https://conductscience.org/library/papers/3401060PubMed
1561799Cutaneous melanomas exhibiting unusual biologic behavior.World J Surg1992https://conductscience.org/library/papers/1561799PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3936263

GET https://conductscience.org/api/papers/v1/3936263/authors